Heritage Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
2,369
+185
| +8% | +$97.1K | 0.14% | 145 |
|
|
2025
Q1 | $1.39M | Sell |
2,184
-227
| -9% | -$144K | 0.17% | 131 |
|
|
2024
Q4 | $1.72M | Buy |
+2,411
| New | +$1.72M | 0.2% | 115 |
|
|
2024
Q2 | $2.41M | Buy |
2,291
+26
| +1% | +$27.3K | 0.32% | 87 |
|
|
2024
Q1 | $2.18M | Buy |
2,265
+19
| +0.8% | +$18.3K | 0.29% | 92 |
|
|
2023
Q4 | $1.97M | Buy |
2,246
+118
| +6% | +$104K | 0.28% | 92 |
|
|
2023
Q3 | $1.75M | Buy |
2,128
+42
| +2% | +$34.6K | 0.27% | 93 |
|
|
2023
Q2 | $1.5M | Buy |
2,086
+2
| +0.1% | +$1.44K | 0.22% | 104 |
|
|
2023
Q1 | $1.71M | Buy |
2,084
+59
| +3% | +$48.5K | 0.27% | 98 |
|
|
2022
Q4 | $1.46M | Buy |
2,025
+98
| +5% | +$70.7K | 0.24% | 105 |
|
|
2022
Q3 | $1.33M | Sell |
1,927
-739
| -28% | -$509K | 0.23% | 106 |
|
|
2022
Q2 | $1.58M | Sell |
2,666
-41
| -2% | -$24.2K | 0.26% | 98 |
|
|
2022
Q1 | $1.89M | Buy |
2,707
+166
| +7% | +$116K | 0.27% | 97 |
|
|
2021
Q4 | $1.61M | Buy |
2,541
+1,020
| +67% | +$644K | 0.21% | 110 |
|
|
2021
Q3 | $920K | Buy |
1,521
+340
| +29% | +$206K | 0.13% | 136 |
|
|
2021
Q2 | $660K | Sell |
1,181
-214
| -15% | -$120K | 0.09% | 160 |
|
|
2021
Q1 | $660K | Buy |
1,395
+132
| +10% | +$62.5K | 0.1% | 153 |
|
|
2020
Q4 | $610K | Buy |
1,263
+25
| +2% | +$12.1K | 0.1% | 151 |
|
|
2020
Q3 | $693K | Buy |
1,238
+102
| +9% | +$57.1K | 0.13% | 129 |
|
|
2020
Q2 | $708K | Buy |
+1,136
| New | +$708K | 0.14% | 128 |
|
|
2019
Q1 | – | Sell |
-26
| Closed | -$10K | – | 360 |
|
|
2018
Q4 | $10K | Hold |
26
| – | – | ﹤0.01% | 313 |
|
|
2018
Q3 | $11K | Hold |
26
| – | – | ﹤0.01% | 313 |
|
|
2018
Q2 | $9K | Buy |
+26
| New | +$9K | ﹤0.01% | 315 |
|